0000899243-15-010387.txt : 20151223
0000899243-15-010387.hdr.sgml : 20151223
20151223195516
ACCESSION NUMBER: 0000899243-15-010387
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151221
FILED AS OF DATE: 20151223
DATE AS OF CHANGE: 20151223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTODYN INC
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gould Gregory A
CENTRAL INDEX KEY: 0001252905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 151306779
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER NAME:
FORMER CONFORMED NAME: GOULD GREGORY A
DATE OF NAME CHANGE: 20030708
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-21
0
0001175680
CYTODYN INC
CYDY
0001252905
Gould Gregory A
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
1
0
0
0
Stock Options (right to buy)
2.00
2015-12-21
4
D
0
50000
A
2016-08-08
Common Stock
50000
0
D
Stock Options (right to buy)
2.00
2015-12-21
4
A
0
50000
A
2021-08-08
Common Stock
50000
50000
D
Stock Options (right to buy)
1.55
2015-12-21
4
D
0
25000
A
2017-06-01
Common Stock
25000
0
D
Stock Options (right to buy)
1.55
2015-12-21
4
A
0
25000
A
2022-06-01
Common Stock
25000
25000
D
Stock Options (right to buy)
0.975
2015-12-21
4
D
0
50000
A
2020-06-01
Common Stock
50000
0
D
Stock Options (right to buy)
0.975
2015-12-21
4
A
0
50000
A
2025-06-01
Common Stock
50000
50000
D
The reported transactions involve the amendment of certain outstanding options to extend the expiration date of each by a period of five years, resulting in (for purposes of Section 16 of the Exchange Act of 1934, as amended) the deemed cancellation of the "old" option and the grant of a replacement option. There have been no changes in the exercise prices of such options, which were all at or above the closing sale price of the issuer's common stock as of the date of the reported transactions.
Such options were fully vested and exercisable as of the date of the reported transactions.
Such options were originally granted on June 1, 2015 and provide for vesting in four equal quarterly installments commencing on September 1, 2015.
/s/ Michael D. Mulholland, as attorney-in-fact
2015-12-23